News

New diabetes drug to be trialled in Birmingham

Researchers from the Diabetes Research Unit and the Clinical Research Facility at the Queen Elizabeth Hospital, Birmingham are currently recruiting patients with type 1 diabetes to a trial for a new drug which could change the future of treatment for the condition. The Birmingham trial will be led by Dr Parth Narendran, together with research … Continue reading “New diabetes drug to be trialled in Birmingham”

Expert warns over little room for complacency over fall in twin stillbirth rates

A leading expert in fetal medicine at the University of Birmingham has warned that there is ‘little room for complacency’ over a fall in twin stillbirth rates as the reason for this phenomenon are complex. In a paper published today (November 27th 2018) in BJOG: An International Journal of Obstetrics & Gynaecology, Mark Kilby, Professor … Continue reading “Expert warns over little room for complacency over fall in twin stillbirth rates”

Abingdon Health launches app to transform a smartphones into rapid analytical tools

Abingdon Health, a resident at BioHub Birmingham® at the heart of the BHP campus,  has launched an intuitive software application called AppDx. The app enables a smartphone to ‘read’ lateral flow test lines, using the inbuilt camera, which translates the image into numerical data. The app allows rapid analytical testing from any location, meeting the increasing … Continue reading “Abingdon Health launches app to transform a smartphones into rapid analytical tools”

Integrated COPD study sees hospitals and GPs working together

Hundreds of patients with chronic obstructive pulmonary disease (COPD) have been recruited to a pioneering study featuring collaboration between primary and secondary care. Led by Heartlands Hospital, part of BHP founder member University Hospitals Birmingham NHS Foundation Trust (UHB), the study has rolled out across all GP practices in Birmingham. Over 700 patients have already … Continue reading “Integrated COPD study sees hospitals and GPs working together”

New partner announced as part of lung cancer research

Mirati Therapeutics, Inc. has been announced as the latest partner of Cancer Research UK’s Stratified Medicine Programme which is being carried out in collaboration with the University of Birmingham Cancer Research Clinical Trials Unit. The partnership will make Mirati’s experimental drug, sitravatinib, available for inclusion in the programme through the National Lung Matrix Trial – … Continue reading “New partner announced as part of lung cancer research”